DKS Co (4461) Q1 2025 earnings summary

Executive summary

• Net sales rose 26.3% year-over-year to ¥17,531 million for the three months ended June 30, 2024, driven by strong growth in Functional Materials and increased sales in Surfactants and Amenity Materials.

• Operating income reached ¥1,058 million, reversing an operating loss of ¥572 million in the prior year period; profit attributable to owners of parent was ¥608 million, compared to a loss of ¥477 million last year.

• The company is in the final year of its five-year medium-term plan, focusing on Electronics & Information, Environment & Energy, and Life Sciences.

Financial highlights

• Gross profit increased to ¥4,081 million from ¥2,300 million year-over-year.

• Ordinary income was ¥1,194 million, compared to an ordinary loss of ¥557 million in the same period last year.

• Comprehensive income surged to ¥1,480 million from ¥16 million year-over-year.

• Basic earnings per share improved to ¥63.63 from a loss of ¥49.96 per share.

Outlook and guidance

• Full-year net sales forecast is ¥70,000 million (up 10.9% year-over-year), with operating income projected at ¥4,000 million (up 92.6%).

• Profit attributable to owners of parent is forecast at ¥2,000 million (up 70.2%), with basic EPS of ¥208.99.

• No changes to previously announced earnings forecasts.